Related topics: Industry Drivers
Gilead Sciences is laying off up to 66 people as it closes its offices in Boulder and Westminster, Colorado, US to consolidate its operations in California.
The biotech has chosen to close the Colorado offices following the $1.4bn (€1bn) acquisition of California-based CV Therapeutics. This created an overlap in expertise that Gilead is resolving by closing the Colorado offices.
Gilead hopes to relocate 73 of the 139 staff that work in the Colorado offices. The offices will close at the end of 2009 or in the first two weeks of next year.
Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
